Literature DB >> 11599299

Formation and effects of neuroactive steroids in the central and peripheral nervous system.

R C Melcangi1, V Magnaghi, M Galbiati, L Martini.   

Abstract

This chapter summarizes several observations that emphasize the importance of neuroactive steroids in the physiology of the central and peripheral nervous systems. A new, and probably important, concept is emerging: Neuroactive steroids not only modify neuronal physiology but also intervene in the control of glial cell functions. The data presented here underscore that (1) the mechanism of action of the various steroidal molecules may involve both classical (progesterone and androgens) and nonclassical steroid receptors [gamma-aminobutyric acid type A (GABAA) receptor], (2) in many instances, the actions of hormonal steroids are not due to their native molecular forms but to their 5 alpha- and 3 alpha,5 alpha-reduced metabolites, (3) several neuroactive steroids exert dramatic actions on the proteins proper of the peripheral myelin (e.g., glycoprotein Po and peripheral myelin protein 22), and (4) the effects of steroids and of their metabolites might have clinical significance in cases in which the rebuilding of the peripheral myelin is needed (e.g., aging, peripheral injury).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599299     DOI: 10.1016/s0074-7742(01)46062-4

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  16 in total

Review 1.  Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.

Authors:  Emanuela Leonelli; Marinella Ballabio; Antonio Consoli; Ilaria Roglio; Valerio Magnaghi; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes.

Authors:  Eunsook Lee; Marta Sidoryk-Wêgrzynowicz; Ning Wang; Anton Webb; Deok-Soo Son; Kyuwon Lee; Michael Aschner
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Neuroprotective effects of neuroactive steroids in the spinal cord and peripheral nerves.

Authors:  Roberto C Melcangi; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Puberty and structural brain development in humans.

Authors:  Megan M Herting; Elizabeth R Sowell
Journal:  Front Neuroendocrinol       Date:  2016-12-19       Impact factor: 8.606

5.  Inhibition of miR-181a protects female mice from transient focal cerebral ischemia by targeting astrocyte estrogen receptor-α.

Authors:  Creed M Stary; Lijun Xu; Le Li; Xiaoyun Sun; Yi-Bing Ouyang; Xiaoxing Xiong; Jing Zhao; Rona G Giffard
Journal:  Mol Cell Neurosci       Date:  2017-05-15       Impact factor: 4.314

6.  Progesterone, administered before kainic acid, prevents decrements in cognitive performance in the Morris Water Maze.

Authors:  Cheryl A Frye; Alicia Walf
Journal:  Dev Neurobiol       Date:  2011-02       Impact factor: 3.964

7.  Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells.

Authors:  Valerio Magnaghi; Marinella Ballabio; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  Progesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy.

Authors:  Paolo Milani; Mauro Mondelli; Federica Ginanneschi; Riccardo Mazzocchio; Alessandro Rossi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-04-26

9.  SRC-1 is involved in the control of the gene expression of myelin protein Po.

Authors:  Ilaria Teresa Rita Cavarretta; Luciano Martini; Marcella Motta; Carolyn Louise Smith; Roberto Cosimo Melcangi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  The neurosteroid allopregnanolone modulates specific functions in central and peripheral glial cells.

Authors:  Alessandro Faroni; Valerio Magnaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.